News Mounjaro and Zepbound shortages over, declares FDA The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in
News GSK plans $800m US manufacturing investment GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.